Nike is set to replace its chief financial officer with David Denton, a finance executive from Pfizer, as the company continues efforts to improve performance. Multiple outlets report that Denton will take over the CFO role on Aug. 17. Before joining Nike, Denton has led Pfizer’s finances since 2022, according to coverage describing his tenure at the pharmaceutical company. The change follows ongoing scrutiny of Nike’s turnaround progress, with reports characterizing the company’s recent period as a slower-than-expected improvement. Other details of Nike’s transition plan, including who Denton will succeed and whether there will be an interim CFO, are not specified in the provided excerpts. The appointments are presented as a leadership move intended to bring experienced financial management to Nike’s executive team, while the company works through its broader operational and strategic challenges.